Showing results (581-590 of 643) with videos related to
Sort By:
Pageof 65
Immunity|July 21, 2016
Antimicrobial Peptide LL37 and MAVS Signaling Drive Interferon-β Production by Epidermal Keratinocytes during Skin InjuryLing-Juan Zhang, George L Sen, Nicole L Ward, et al.Cephalalgia : an International Journal of Headache|October 27, 2010
Osmophobia in migraine classification: a multicentre study in juvenile patientsD De Carlo, L Dal Zotto, E Perissinotto, et al.The Journal of Clinical Investigation|January 9, 2024
Increased LL37 in psoriasis and other inflammatory disorders promotes LDL uptake and atherosclerosisYoshiyuki Nakamura, Nikhil N Kulkarni, Toshiya Takahashi, et al.The Journal of Investigative Dermatology|July 21, 2023
Genetic and Functional Analyses of Cutibacterium Acnes Isolates Reveal the Association of a Linear Plasmid with Skin InflammationAlan M O'Neill, Kellen J Cavagnero, Jason S Seidman, et al.Nature Medicine|December 8, 2009
Commensal bacteria regulate Toll-like receptor 3-dependent inflammation after skin injuryYuping Lai, Anna Di Nardo, Teruaki Nakatsuji, et al.Dermatologic Therapy|June 1, 2020
Chemical and mechanical characterization of hyaluronic acid hydrogel cross-linked with polyethylen glycol and its use in dermatologyNicola Zerbinati, Cristina Esposito, Giovanna Cipolla, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1996
Multicenter randomized controlled clinical trial to evaluate cardioprotection of dexrazoxane versus no cardioprotection in women receiving epirubicin chemotherapy for advanced breast cancerM Venturini, A Michelotti, L Del Mastro, et al.Journal of Innate Immunity|July 12, 2014
Novel role of the antimicrobial peptide LL-37 in the protection of neutrophil extracellular traps against degradation by bacterial nucleasesAriane Neumann, Lena Völlger, Evelien T M Berends, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1996
High-dose versus low-dose cisplatin in combination with cyclophosphamide and epidoxorubicin in suboptimal ovarian cancer: a randomized study of the Gruppo Oncologico Nord-OvestP F Conte, M Bruzzone, F Carnino, et al.Gene Therapy|March 2, 2012
Intrarectal administration of mCRAMP-encoding plasmid reverses exacerbated colitis in Cnlp(-/-) miceE K K Tai, W K K Wu, X J Wang, et al.Pageof 65